These effects, along with a former report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two guidance the thought of targeting ACKR3 as a novel method to modulate the opioid process, which could open up new therapeutic avenues for opioid-similar disorders. (3) Apart from in the https://robertoi416zio3.blogspothub.com/profile